glp-1 gip lilly LY3437943, a novel triple glucagon, GIP, and receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Eli Lilly just made history
Description
Tip: Prioritise protein (80120g/day depending on body size) and add strength-based movement like yoga, bodyweight exercises, or resistance bands
Maximizing the value of GLP-1RAs and next-generation pleiotropic drugs will demand effective navigation of data management and analysis, deals and licensing, regulatory exclusivity, and strategic patent prosecution

Lawsuits filed against Eli Lilly are being consolidated into the same multidistrict litigation alongside claims against Novo Nordisk, as many plaintiffs allege similar injuries and legal issues

Since GLP 1 & GIP weight loss medications slow digestion, eating smaller meals spaced throughout the day rather than large meals can help prevent discomfort

And which brands and businesses are making the biggest bets